Sign in

CIK 0000812796

  • Non-accelerated filer
  • Smaller reporting company

SOLIGENIX, INC.

Sign in to watch
Ticker
SNGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
411505029
Phone
+1 609-538-8200
Business address
29 EMMONS DRIVE, SUITE B-10, PRINCETON, NJ, 08540
Former names
SOLIGENIX, INC., DOR BIOPHARMA INC, ENDOREX CORP, IMMUNOTHERAPEUTICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2015-06-18 RUBIN ROBERT J. Director Grant or award · Stock Option (Right to Buy) +19,868 19,868
2015-06-18 ZELDIS JEROME B Director Grant or award · Stock Option (Right to Buy) +19,868 19,868
2015-04-09 ZELDIS JEROME B Director Exercise or conversion +17,857 $0.61 $11K 66,666
2015-04-09 ZELDIS JEROME B Director Exercise or conversion · Common Stock Warrant −17,857 0
2015-04-09 Brownlie Keith L Director Exercise or conversion +14,286 $0.61 $9K 50,000
2015-04-09 Brownlie Keith L Director Exercise or conversion · Common Stock Warrant −14,286 0
2014-12-24 SCHABER CHRISTOPHER J Chairman, CEO and President Purchase · Common Stock Warrant +4,959 4,959
2014-12-24 Warusz Joseph Michael VP of Finance/Acting CFO Purchase · Common Stock Warrant +4,959 4,959
2014-12-22 SCHABER CHRISTOPHER J Chairman, CEO and President Purchase +8,265 $1.21 $10K 75,761
2014-12-22 Warusz Joseph Michael VP of Finance/Acting CFO Purchase +8,265 $1.21 $10K 12,955
2014-12-04 Warusz Joseph Michael VP of Finance/Acting CFO Grant or award · Option (Right to Buy) +45,000 45,000
2014-12-04 Straube Richard Sr VP & Chief Medical Officer Grant or award · Stock Option (Right to Buy) +50,000 50,000
2014-12-04 SCHABER CHRISTOPHER J Chairman, CEO and President Grant or award · Option (Right to Buy) +100,000 100,000
2014-08-05 Brughera Marco Maria Director Exercise or conversion +7,500 $2.01 $15K 7,500
2014-08-05 Brughera Marco Maria Director Exercise or conversion · Stock Option (Right to Buy) −7,500 7,500
2014-06-19 LAPOINTE ANTHONY GREGG Director Grant or award · Stock Option (Right to Buy) +13,669 13,669
2014-06-19 Brughera Marco Maria Director Grant or award · Stock Option (Right to Buy) +13,669 13,669
2014-06-19 Brownlie Keith L Director Grant or award · Stock Option (Right to Buy) +13,669 13,669
2014-06-19 ZELDIS JEROME B Director Grant or award · Stock Option (Right to Buy) +13,669 13,669
2014-06-19 RUBIN ROBERT J. Director Grant or award · Stock Option (Right to Buy) +13,669 13,669

Page 11 of 14 · 277 trades